Hodgkin lymphoma among US solid organ transplant recipients

Transplantation

Volumn 90, Issue 9, 2010, Pages 1011-1015

  Quinlan, Scott C ^a   Landgren, Ola ^a   Morton, Lindsay M ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epstein Barr virus; Hodgkin lymphoma; Transplantation; United States

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CANCER REGISTRY; CANCER RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GENDER; GRAFT RECIPIENT; HAZARD RATIO; HEART LUNG TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANT REGISTRY; INFANT; KIDNEY PANCREAS TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEROLOGY; STANDARDIZED INCIDENCE RATIO; UNITED STATES;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 78650282088     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f5c3a6     Document Type: Article

References (23)

1. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80: S254.
2. Grulich AE, van Leeuwen MT, Falster MO, etal. Incidenceof cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59.
3. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905.
4. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
5. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747.
6. Harris NL, Swerdlow SH, FrizzeraG,et al. Post-transplant lymphopro-liferative disorders. In: Jaffe ES, Harris NL, Stein H, et al., eds. Pathology and genetics-Tumours of haematopoietic and lymphoid tissues. Lyon, France, IARC Press 2001, pp 264-269.
7. Bierman PJ, Vose JM, Langnas AN, et al. Hodgkin's disease following solid organ transplantation. Ann Oncol 1996; 7: 265.
8. Garnier JL, Lebranchu Y, Dantal J, et al. Hodgkin's disease after transplantation. Transplantation 1996; 61: 71.
9. Knight JS, Tsodikov A, Cibrik DM, et al. Lymphoma after solid organ transplantation: Risk, response to therapy, and survival at a transplantation center. J Clin Oncol 2009; 27: 3354.
10. Semakula B, Rittenbach JV, Wang J. Hodgkin lymphoma-like post-transplantation lymphoproliferative disorder. Arch Pathol Lab Med 2006; 130: 558.
11. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006; 108: 3786.
12. Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation 2005; 80: 193.
13. Morton LM, Landgren O, Chatterjee N, et al. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007; 110: 4599.
14. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222.
15. Epstein-Barr virus and lymphoproliferative disorders after transplantation. Am J Transplant 2004; 4(suppl 10): 59.
16. Cockfield SM. Identifying the patient at risk for post-transplant lym-phoproliferative disorder. Transpl Infect Dis 2001; 3: 70.
17. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003; 349: 1324.
18. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: A review of the epidemiological evidence. J Intern Med 2008; 264: 537.
19. Ambinder RF. Epstein-Barr virus and Hodgkin lymphoma. Hematol-ogy Am Soc Hematol Educ Program 2007; 204.
20. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265.
21. Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007; 21: 825.
22. Caillard S, Agodoa LY, Bohen EM, et al. Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: Characteristics, risk factors and prognosis Transplantation 2006; 81: 888.
23. Levine GN, McCullough KP, Rodgers AM, et al. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6: 1228.